Essity AB stock (SE0009922164): shares steady as investors digest Q1 2026 results and cash return plans

Essity AB shares on Nasdaq Stockholm traded broadly stable on 05/29/2026 as the Swedish hygiene and health group continued to be driven by its Q1 2026 report, dividend decision, and ongoing share buyback, keeping investor focus on cash returns and profitability trends.

Essity AB shares traded broadly unchanged on Nasdaq Stockholm on 05/29/2026, as investors in Sweden continued to digest the company’s Q1 2026 figures, the recently approved dividend for the 2025 financial year, and the ongoing share buyback program, which together underline the group’s current capital-allocation priorities, according to trading data from Nasdaq Nordic as of 05/29/2026 and Essity’s investor information as of 04/26/2026.

The stock traded at around SEK 260 on 05/29/2026 on Nasdaq Stockholm under the ticker ESSITY B, according to Nasdaq Nordic data as of 05/29/2026, placing the company firmly within the larger Swedish equity universe and attracting attention from both domestic and international investors.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Essity B
• Sector/industry: Hygiene and health products (tissue, personal care, professional hygiene)
• Headquarters/country: Stockholm, Sweden
• Core markets: Europe, North America, Latin America, Asia
• Key revenue drivers: Consumer tissue, professional hygiene solutions, incontinence products, feminine care, medical solutions
• Home exchange/listing venue: Nasdaq Stockholm (ESSITY B)
• Trading currency: SEK

Essity AB: core business model

Essity AB focuses on branded hygiene and health offerings ranging from tissue and paper-based products to incontinence and medical solutions, with revenue largely generated by recurring demand for everyday consumer and professional hygiene products sold across Europe and other international markets.

Valuation metrics and multiples for Essity AB

On 05/29/2026, Essity AB’s market valuation on Nasdaq Stockholm reflected investor expectations for cash generation and margin resilience in the hygiene and health space, with pricing informed by the company’s most recent financial communication for Q1 2026 and the full year 2025 published on 04/26/2026. In its Q1 2026 report released on 04/26/2026, Essity reported continued profitability and cash flow from its tissue and personal care operations, which underpin the company’s ability to pay dividends and execute share repurchases, according to the Q1 2026 presentation and related materials as of 04/26/2026.

Essity has communicated a dividend for the 2025 financial year in connection with its annual meeting documentation in 2026, and the decision on shareholder remuneration, together with the existing share buyback authorization, is a key component of the group’s equity story for investors following Swedish large caps. The valuation of Essity AB on 05/29/2026 therefore factors in both its cash distribution policy and its operating performance in Q1 2026, as disclosed by the company’s investor relations team on 04/26/2026, even though precise multiples such as P/E and EV/EBITDA depend on the latest consensus estimates and are subject to change as analysts update their models.

Conclusion

Essity AB’s largely stable share price on Nasdaq Stockholm on 05/29/2026 reflects a market that is weighing the group’s Q1 2026 operating performance and 2025 dividend decision against the broader backdrop of European consumer and healthcare stocks. The current valuation framework for Essity AB integrates expectations around continued cash generation from its hygiene and health portfolio and the impact of its share buyback and dividend policy on total shareholder returns, without pointing to any single dominant near-term catalyst.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.